Franklin Resources
KRSA

Franklin Resources’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Franklin Resources’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-564
Closed -$34.2K – 2732
2023
Q1 		$34.2K Hold
564
– – ﹤0.01% 2221
2022
Q4 		$51.8K Hold
564
– – ﹤0.01% 2214
2022
Q3 		$68K Buy
564
+7
+1% +$120 ﹤0.01% 2164
2022
Q2 		$43K Sell
557
-269
-33% -$3.85K ﹤0.01% 2256
2022
Q1 		$128K Hold
826
– – ﹤0.01% 2247
2021
Q4 		$199K Sell
826
-3
-0.4% -$142 ﹤0.01% 2242
2021
Q3 		$356K Buy
+829
New +$54.3K ﹤0.01% 2020

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Franklin Resources's KRSA Position: Q2 2023 in Review

Franklin Resources sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 564 shares — an estimated $34.2K sold.

Franklin Resources first reported a position in KRSA in Q3 2021 and held it in 7 quarters. The position peaked at $356K in Q3 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • Franklin Resources reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Franklin Resources sold 564 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $34.2K.
  • Franklin Resources first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Franklin Resources's Korsana Biosciences, Inc. Common Stock position peaked at $356K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Franklin Resources's 13F filing for Q2 2023, filed 11 Aug 2023.